{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":52,"n_cols":5,"rows_kept":52,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[10,2,10,3],[11,2,11,3],[18,2,18,3],[18,4,18,5],[19,2,19,3],[19,4,19,5],[20,2,20,3],[20,4,20,5],[21,2,21,3],[22,2,22,3],[25,2,25,3],[26,2,26,3],[27,2,27,3],[29,2,29,3],[46,2,46,3],[47,2,47,3],[50,2,50,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910702009103321"]
[null,null,"Autore",null,"Vertin Keith"]
[null,null,"Titolo",null,"Comparative emissions testing of vehicles aged on E0, E15 and E20 fuels [[electronic resource] /] / Keith Vertin, Gerard Glinsky, and Aaron Reek"]
[null,null,"Pubbl/distr/stampa",null,"Golden, Colo. : , : National Renewable Energy Laboratory, , [2012]"]
[null,null,"Descrizione fisica",null,"1 online resource (iv, 69 pages) : color illustrations"]
[null,null,"Collana",null,"NREL/SR ; ; 5400-55778"]
[null,null,"Soggetti",null,"Alternative fuel vehicles - Motors - Exhaust gas - Testing"]
[{"$nulls":4},"Automobiles - Motors - Exhaust gas - Testing"]
[{"$nulls":4},"Combustion gases - Testing"]
[{"$nulls":4},"Ethanol as fuel - Testing"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Title from title screen (viewed on Sept. 24, 2012)."]
[{"$nulls":4},"\"August 2012.\""]
[{"$nulls":4},"\"NREL technical monitor: Aaron Williams.\""]
[{"$nulls":4},"\"Prepared under Subcontract Nos. JEV-7-77439-01, JCG-9-99141-01, and JXH-1-11668-01.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (page 45)."]
[null,"2.","Record Nr.",null,"UNISA996339118303316"]
[null,null,"Autore",null,"Ritchie CW"]
[null,null,"Titolo",null,"Therapeutic Strategies in Dementia [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"Oxford, : Atlas Medical Publishing Ltd, 2006"]
[null,null,"ISBN",null,"1-280-75121-5"]
[{"$nulls":4},"9786610751211"]
[{"$nulls":4},"1-84692-560-6"]
[null,null,"Descrizione fisica",null,"1 online resource (358 p.)"]
[null,null,"Collana",null,"Therapeutic Strategies"]
[null,null,"Disciplina",null,"616.8/31"]
[{"$nulls":4},"616.831"]
[null,null,"Soggetti",null,"Alzheimer's disease -- Popular works"]
[{"$nulls":4},"Alzheimer's disease"]
[{"$nulls":4},"Dementia -- Popular works"]
[{"$nulls":4},"Dementia"]
[{"$nulls":4},"Alzheimer Disease"]
[{"$nulls":4},"Central Nervous System Agents"]
[{"$nulls":4},"Tauopathies"]
[{"$nulls":4},"Brain Diseases"]
[{"$nulls":4},"Delirium, Dementia, Amnestic, Cognitive Disorders"]
[{"$nulls":4},"Therapeutic Uses"]
[{"$nulls":4},"Pharmacologic Actions"]
[{"$nulls":4},"Central Nervous System Diseases"]
[{"$nulls":4},"Mental Disorders"]
[{"$nulls":4},"Neurodegenerative Diseases"]
[{"$nulls":4},"Nervous System Diseases"]
[{"$nulls":4},"Chemical Actions and Uses"]
[{"$nulls":4},"Diseases"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Contents; Contributors; Foreword; Preface; Section I: Current pharmacological approaches in dementia; Section II: Biological developments and future therapies; Section III: Management of non-cognitive issues in dementia; Section IV: Treatment of non-Alzheimer's disease cognitive impairment; Abbreviations; Index"]
[null,null,null,"Sommario/riassunto","Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work"]